Spots Global Cancer Trial Database for Study to Evaluate the Safety and Efficacy of Androxal Treatment in Men With Secondary Hypogonadism
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Study to Evaluate the Safety and Efficacy of Androxal Treatment in Men With Secondary Hypogonadism
Official Title: An Open-Label, Multiple Center Study to Evaluate the Safety and Efficacy of Androxal™ Treatment in Men With Secondary Hypogonadism Who Completed ZA-003
Study ID: NCT01067365
Conditions
Study Description
Brief Summary: Subjects who completed ZA-003 were eligible to receive an additional year of treatment in this extension study.
Detailed Description: The objectives of this study were to evaluate the safety and efficacy of Androxal® administered orally once daily for one year in men with secondary hypogonadism and who had completed ZA-003.
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: MALE
Healthy Volunteers: No
Locations
Alabama Clinical Therapeutics, LLC, Birmingham,, Alabama, United States
Medial Affiliated Research Center, Inc., Huntsville, Alabama, United States
Northern California Research Corp, Carmichael, California, United States
Prime-Care Clinical Research, Mission Viejo, California, United States
Harbor-UCLA Medical Center, Torrance, California, United States
Chase Medical Research, LLC, Waterbury, Connecticut, United States
Southeastern Research Group, Inc., Tallahassee,, Florida, United States
Northeast Indiana Research, LLC, Fort Wayne, Indiana, United States
Commonweatlh Biomedical Research, Madisonville,, Kentucky, United States
The Center for Sexual Medicine at Sheppard Pratt, Baltimore, Maryland, United States
Office of Keith Pierce, MD, Livonia, Michigan, United States
Office of Michael Mall, MD, Las Vegas, Nevada, United States
Office of Stephen Miller, MD, Las Vegas, Nevada, United States
Advanced Biomedical Research, Inc., Hackensack, New Jersey, United States
Office of Gary S. Karlin, MD, Lawrenceville, New Jersey, United States
Medical Research Associates of Nashville, Nashville, Tennessee, United States
Urology San Antonio Research, PA, San Antonio, Texas, United States
Salt Lake Research, Salt Lake City, Utah, United States
Contact Details
Name: Andre van As, MD, PhD
Affiliation: Repros Therapeutics Inc.
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
